BioInformatics, LLC New Market Research Report – NGS Library Prep Market Scan: Pinpointing Customer Needs and Opportunities for Growth
Arlington, VA (PRWEB) November 21, 2013 -- NGS Library Prep Market Scan: Pinpointing Customer Needs and Opportunities for Growth (13-006) —Get free dataset with report purchase until December 20, 2013
Next generation sequencing (NGS) is a disruptive technology with an ever-increasing number of users and applications. As such, it is the fastest growing and most attractive segment of all the different technologies that comprise the genomics universe. On a global scale, we estimate that about 22% of life science researchers use NGS in their work.
BioInformatics LLC's newest report, NGS Sample Prep Market Scan: Pinpointing Customer Needs and Opportunities for Growth, targets the manufacturers and suppliers of NGS sample prep to help identify the usage, preferences and differentiators in a market that has attracted a significant number of players.
“Suppliers recognize that there are fewer barriers to entry in the sample prep space compared to developing new sequencing platforms, thereby making sample prep product development more attractive—and on the rise,” says Robin Rothrock, Ph.D., Director of Publications at BioInformatics LLC. Dr. Rothrock adds: “In this study, we will identify bottlenecks and areas that are causing the most frustration to researchers, but also point directly to opportunities for innovation. With literally hundreds of products available from dozens of suppliers, the ability to fine-tune your unique message, value proposition and product portfolio is more important than ever.”
This study covers areas of growth by application, segment and region. It also examines how automation can conceivably change the speed, consistency, accuracy and ease with which researchers can expect to conduct next generation sequencing now and in the future.
To learn more about NGS Sample Prep Market Scan: Pinpointing Customer Needs and Opportunities for Growth (13-006), a complimentary report brochure is available at:
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 73,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
For more information contact:
Angela Fernandez
Marketing Coordinator
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA 22201
703.778.3080 x14 (phone)
a.fernandez(at)gene2drug(dot)com
http://www.gene2drug.com/
Angela Fernandez, BioInformatics LLC, http://www.gene2drug.com, +1 (703) 778-3080 Ext: 14, [email protected]
Share this article